Company Filing History:
1 out of 81 
1 out of 8 Years Active: 2009
Title: Takashi Kuroyanagi: Innovator in Hemoglobin Determination Methods
Introduction
Takashi Kuroyanagi is a notable inventor based in Aichi, Japan. He has made significant contributions to the field of medical diagnostics, particularly in the determination of glycated hemoglobin.
Latest Patents
Kuroyanagi holds a patent for a method of determining the glycated β-chain N-terminal of glycated hemoglobin. This innovative method utilizes enzymes to achieve specific determination without the need for separation operations. The patent also includes a determination reagent kit that employs a protease capable of cleaving glycated amino acids and peptides from the β-chain without affecting the α-chain. This advancement allows for more efficient and accurate measurement of hemoglobin A1c levels.
Career Highlights
Throughout his career, Kuroyanagi has worked with prominent companies such as Asahi Kasei Pharma Corporation and Ichibiki Co., Ltd. His experience in these organizations has contributed to his expertise in the field of enzymatic assays and medical diagnostics.
Collaborations
Kuroyanagi has collaborated with notable colleagues, including Takeshi Matsuoka and Shinji Koga. Their combined efforts have furthered research and development in the area of glycated hemoglobin determination.
Conclusion
Takashi Kuroyanagi's innovative work in the field of hemoglobin determination has the potential to enhance diagnostic accuracy and efficiency in medical settings. His contributions are invaluable to the advancement of medical technology.